Pharmacokinetics of imatinib, sildenafil and bosentan when administered alone or in combination in patients with severe pulmonary arterial hypertension

Trial Profile

Pharmacokinetics of imatinib, sildenafil and bosentan when administered alone or in combination in patients with severe pulmonary arterial hypertension

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Nov 2013

At a glance

  • Drugs Imatinib (Primary) ; Bosentan; Sildenafil
  • Indications Pulmonary arterial hypertension
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Nov 2013 New trial record
    • 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top